Volume 13, Issue 3 (Autumn 2016)                   Sci J Iran Blood Transfus Organ 2016, 13(3): 197-206 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yazhan S, Sohrabi E, Jamili P, Saffari S, Mojaddadi M. Frequency of HBV, HCV and HIV infections among Sabzevar blood donors based on demographic characteristics during 2009-2013. Sci J Iran Blood Transfus Organ 2016; 13 (3) :197-206
URL: http://bloodjournal.ir/article-1-998-en.html
Full-Text [PDF 384 kb]   (1468 Downloads)     |   Abstract (HTML)  (6285 Views)
Full-Text:   (2641 Views)
References:
  1. Taheri Azbarmi Z, Nouri S, Joukar F, Jafarshad R, Haajikarimian K, Alinejad S, et al. Transfusion transmitted diseases in Rasht blood donors. Sci J Blood Transfus Organ 2008; 4(5): 337-43. [Article in Farsi]
  2. Bazazataei A, Davarnia B, SadegyyeAharry S, Haghighy S, Azami A. Evaluation of knowledge and attitude of female teachers and students (above 17 years of age) about donation in Ardabil province girl high schools Sci J Iran Blood Transfus Organ 2005; 2(7): 365-72. [Article in Farsi]
  3. Mansour Ghanaei F, Fallah MS, Jafarshad R, Joukar F, Salari A, Tavafzadeh R, et al. Prevalence of hepatitis B and hepatitis C, and their risk factors among Guilan blood donors. Sci J Blood Transfus Organ 2008; 4(5): 331-6. [Article in Farsi]
  4. Yousefinejad V, Esmeil Nasab N, Arabzadeh M, Soori M, Keshvari M, Soltanian E. Effect of education on awareness  level  of  blood  donors  about   transfusion-
 
transmitted  infections.  Sci J  Blood   Transfus   Organ
2008; 4(5): 303-11. [Article in Farsi]
  1. Biedrycki B. Blood transfusions: is "safest ever" safe enough? ONS News 2004; 19(11): 8-9.
  2. Satake M. Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan. Int J Hematol 2004; 80(4): 306-10.
  3. McClelland B, Contreras M. Appropriateness and safety of blood transfusion. BMJ 2005; 330(7483): 104-5.
  4. Rezvan H, Ahmadi J, Farhadi M, Tardyan S. A preliminary study of prevalence of HCV infection in healthy Iranian blood donors. Vox Sang 1994; 67: 149.
  5. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis 2010; 14 Suppl 3: e113-6.
  6. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 2002; 17(10): 1092-7.
  7. Shakeri MT, Nomani H, Mobarhan MG, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon 2013; 13(3): e7723.
  8. Vahid T, Alavian SM, Kabir A, Kafaee J, Yektaparast B. Hepatitis B prevalence and risk factors in blood donors in Ghazvin, IR. Iran. Hepat Mon 2005; 5(4): 117-22.
  9. Salehi M, Alavian SM, Tabatabaei SV, Izadi Sh, Sanei Moghaddam EAmini Kafi-Abad S, et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J 2012; 14(5): 283-8.
  10. Alavian SM, Tabatabaei SV, Ghadimi T, Beedrapour F, Kafi-Abad SA, Gharehbaghian A, et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: A Population-based Study. Int J Prevent Med 2012; 3(11): 770-5.
  11. Kafi-Abad SA, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49(10): 2214-20.
  12. Kasraian L, Jahromi T, Ardeshir S. Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005. Sci J Iran Blood Transfus Organ 2007; 3(5): 373-8. [Article in Farsi]
  13. Choudhury N, Phadke S. Transfusion transmitted diseases. Indian J Pediatr 2001; 68(10): 951-8.
  14. Sorouri Zanjani R, Mazloomzadeh S, Koocheki A, Noori M. Prevalence of Hepatitis B, C and HIV Infection in Blood Donors in Zanjan, 2005-2006. Prev Care Nurs Midwifery J 2013; 3(1): 56-64. [Article in Farsi]
  15. Pillonel J, Le Marrec N, Girault A, David D, Laperche S. Epidemiological surveillance of blood donors and residual risk of blood-borne infections in France, 2001 to 2003. Transfus Clin Biol 2005; 12(3): 239-46. [Article in French]
  16. Yanase Y, Ohida T, Kaneita Y, Agdamag DMD, Leaño PS, Gill CJ. The prevalence of HIV, HBV and HCV among Filipino blood donors and overseas work visa applicants. Bull World Health Organ 2007; 85(2): 131-7.
  17. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA,
    Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 2004; 26(3): 225-8.
  18. Williams AE, Thomson RA, Schreiber GB, Watanabe K, Bethel J, Lo A, et al. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. JAMA 1997; 277(12): 967-72.
  19. Javadzadeh Shahshahani H, Vaziri M, Mansouri F. Seven years trends in prevalence of transfusion-transmissible viral infections in Yazd blood transfusion organization. Iran J Ped Hematol Oncol 2013; 3(3): 119-24.
  20. Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey. J Med Virol 2008; 80(1): 53-7.
  21. Butsashvili M, Tsertsvadze T, McNutt L, Kamkamidze G, Gvetadze R, Badridze N. Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. Eur J Epidemiol 2001; 17(7): 693-5.
  22. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 2004; 25(1): 26-33.
  23. Bani Aghil S, Abbasi S, Arab M, Seyedein M. The prevalence of HCV, HBV, HIV in blood donors of Golestan province, (2006-2008). Medical Laboratory Journal 2009; 3(2): 1-5. [Article in Farsi]
  24. Zou S, Notari I, Edward P, Stramer SL, Wahab F, Musavi F, et al. Patterns of age-and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 2004; 44(11): 1640-7.
  25. Soldan K, Barbara JA, Ramsay ME, Hall AJ. Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sang 2003; 84(4): 274-86.
  26. Attachi Z, Ghafouri M, Hajibaygi B, Assari S, Alavian S. Donor deferral and blood-borne infections in blood donors of Tehran. Sci J Iran Blood Transfus Organ 2006; 2(7): 364-53. [Article in Farsi]
  27. Pourazar A., Akbari N., Hariri M., Yavari F., Akbari Sh. Evaluation of demographic profiles and prevalence of major viral markers in first time vs repeat blood donors in Esfahan. Sci J Iran Blood Transfus Organ 2006; 2(7): 323-9. [Article in Farsi]
 
 
 

 

 
 
Original  Article
 
 
 
 
 
Sci J Iran Blood Transfus Organ 2016; 13(3):
 
 
 
 
 
 
Sci J Iran Blood Transfus Organ 2016; 13(3): 197-206
 
 
 
  Frequency of HBV, HCV and HIV infections among
Sabzevar blood donors based on demographic
 characteristics during 2009-2013
 
Yazhan S.1, Sohrabi E.1, Jamili P.2,3, Saffari S.E.4, Mojadadi M.Sh.5
 
1Student Research Committee, Sabzevar University of Medical Sciences, Sabzevar, Iran
2Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
3Sabzevar Regional Blood Transfusion Center, Sabzevar, Iran
4School of Public Health, Sabzevar University of Medical Sciences, Sabzevar, Iran
5Faculty of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran
 
Abstract
Background and Objectives
Dangerous infections such as hepatitis B, C and HIV can be transmitted through blood transfusion. The purpose of this study was to evaluate the frequency of hepatitis B, C and HIV infections among Sabzevar blood donors based on demographic characteristics, during 2009-2013.
 
Materials and Methods
In this cross-sectional study, required information including demographic characteristics and serologic test results (HBsAg, Anti-HCV, Anti-HIV) of all blood donors during 2009 to 2013 were extracted from records. Data were analyzed using descriptive statistics (frequency and percentage) using SPSS software version 18.
 
Results
The total number of blood donors was 57335 people. Frequency rates of Hepatitis B, Hepatitis C and HIV were 3, 0.2, and 0 per 1000, respectively. The highest and the lowest infection rates were in donors over 50 years and 21-30 years, respectively (7.1 and 2.1 per 1000). The infection frequency was higher in women than men (4.1 and 3.1 per 1000, respectively), and in married than singles (3.3 and 2.5 per 1000). Also, the infections frequency was higher in the first-time donors than regular and multi-time donors with Hepatitis B, Hepatitis C and HIV rates of 11.4, 0.1, and 0.08 per 1000, respectively.
 
Conclusions 
The results show low levels of hepatitis B and C and the absence of HIV infections among Sabzevar blood donors. This indicates the effectiveness of screening methods, and thus the safety of blood products in Sabzevar.
 
Key words: Hepatitis B, Hepatitis C, HIV, Blood Transfusion, Blood Donors, Blood Safety
 
 
 
 
Received: 23 Nov 2015
Accepted:11 May 2016
 
 

Correspondence: Mojadadi M.Sh., PhD of Immunology. Assistant Professor of Immunology, Department of Immunology of Faculty of Medicine, Sabzevar University of Medical Sciences.
P.O.Box: 319, Sabzevar, Iran. Tel: (+9851) 44446070; Fax: (+9851) 52523748
E-mail: mojadadim@medsab.ac.ir
Type of Study: Research | Subject: Blood donation
Published: 2016/09/7

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb